Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1085809

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1085809

Cancer Cell Market, by Cancer Cell Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.

Market Dynamics

Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
  • This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global cancer cell market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market

Detailed Segmentation:

  • Global Cancer Cell Market, By Cancer Cell Type:
    • Carcinomas
    • Sarcomas
    • Leukemia
    • Others
  • Global Cancer Cell Market, By Application:
    • Chemotherapy.
    • Radiation Therapy
    • Immunotherapy
    • Hormone Therapy
    • Targeted Drug Therapy
    • Others
  • Global Cancer Cell Market, By End User :
    • Hospitals & Clinics
    • Specialty Clinics
    • Diagnostic Laboratories
  • Global Cancer Cell Market, By Region:
    • North America
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Cancer Cell Type:
      • Carcinomas
      • Sarcomas
      • Leukemia
      • Others
      • By Application:
      • Chemotherapy.
      • Radiation Therapy
      • Immunotherapy
      • Hormone Therapy
      • Targeted Drug Therapy
      • Others
      • By End User :
      • Hospitals & Clinics
      • Specialty Clinics
      • Diagnostic Laboratories
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott Laboratories.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novartis International AG
    • Arcellx
    • Autolus Therapeutics
    • Kite Pharma
    • Cellectis
    • Celyad Oncology
    • Crescendo Biologics Limited
    • GammaDelta Therapeutics Ltd.
    • Bio-Rad Laboratories Inc
    • QIAGEN Inc
    • Thermo Fisher Scientific
    • Merck Millipore
    • Siemens Healthineers AG
    • GE Healthcare

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4338

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Cancer Cell Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Developments
  • New Product Launches/Approvals
  • Merger-Acquisition Scenario
  • Regulatory Scenario
  • Pipeline Analysis
  • Epidemiology
  • PEST Analysis
  • Reimbursement

4. Global Cancer Cell Market - Impact of Coronavirus (COVID-19) Pandemic

  • Government Initiative To Combat Covid-19
  • COVID 19 Impact on Cancer Patients
  • COVID 19 Impact on Oncology Treatment

5. Global Cancer Cell Market, By Cancer Cell Type, 2017 - 2028 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Carcinomas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Sarcomas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cancer Cell Market, By Application, 2017 - 2028 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Chemotherapy.
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Radiation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Hormone Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Targeted Drug Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Cancer Cell Market, By End User, 2017 - 2028 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Cancer Cell Market, By Region, 2017 - 2028 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017 - 2028
  • North America
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Cancer Cell Type, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Arcellx
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Autolus Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kite Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cellectis
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celyad Oncology
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Crescendo Biologics Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GammaDelta Therapeutics Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bio-Rad Laboratories Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • QIAGEN Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck Millipore
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Siemens Healthineers AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!